Target Name: LOC340184
NCBI ID: G340184
Review Report on LOC340184 Target / Biomarker Content of Review Report on LOC340184 Target / Biomarker
LOC340184
Other Name(s): uncharacterized LOC340184 | Uncharacterized LOC340184

LOC340184: A Potential Drug Target and Biomarker

LOC340184 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the development and maintenance of blood pressure.

Recent studies have suggested that LOC340184 may be a drug target and biomarker for various diseases, including hypertension, heart failure, and diabetes. This protein has also been shown to be involved in the regulation of blood pressure, which is a critical factor in the development of these diseases.

One of the potential reasons for the involvement of LOC340184 in blood pressure regulation is its role in the regulation of sodium channels. Sodium channels are responsible for the flow of electrical signals through the cells, and they play a crucial role in the regulation of blood pressure.

Research has shown that LOC340184 is involved in the regulation of sodium channels, and that its function in this regard may be important in the development of hypertension. Studies have shown that LOC340184 is expressed in the brain and that it is involved in the regulation of sodium channels in this region. This suggests that LOC340184 may be involved in the development of hypertension by regulating the flow of electrical signals through the sodium channels in the brain.

Another potential reason for the involvement of LOC340184 in blood pressure regulation is its role in the regulation of water channels. Water channels are responsible for the regulation of the movement of water into and out of cells, and they play a crucial role in the regulation of blood pressure.

Research has shown that LOC340184 is involved in the regulation of water channels, and that its function in this regard may be important in the development of heart failure. Studies have shown that LOC340184 is expressed in the heart and that it is involved in the regulation of water channels in this region. This suggests that LOC340184 may be involved in the development of heart failure by regulating the movement of water into and out of the cells in the heart.

In addition to its potential role in the regulation of sodium and water channels, LOC340184 has also been shown to be involved in the regulation of blood pressure. Studies have shown that LOC340184 is involved in the regulation of the contraction and relaxation of blood vessels, which is important in the regulation of blood pressure.

The involvement of LOC340184 in the regulation of blood pressure makes it a potential drug target and biomarker for various diseases, including hypertension, heart failure, and diabetes. These conditions are characterized by high blood pressure, which can lead to a range of serious health problems, including heart attacks, strokes, and diabetes.

In conclusion, LOC340184 is a protein that is expressed in various tissues of the body and is involved in the regulation of various physiological processes, including blood pressure, sodium and water channels, and blood pressure regulation. Its involvement in these processes makes it a potential drug target and biomarker for various diseases, including hypertension, heart failure, and diabetes. Further research is needed to fully understand the role of LOC340184 in these conditions and to develop effective treatments.

Protein Name: Uncharacterized LOC340184

The "LOC340184 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC340184 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682 | LOC400692 | LOC400706 | LOC400707 | LOC400768 | LOC400940 | LOC401021 | LOC401052 | LOC401127 | LOC401261 | LOC401312 | LOC401324 | LOC401357 | LOC401410 | LOC401478 | LOC401480 | LOC401557 | LOC401589 | LOC401703 | LOC401913 | LOC402221 | LOC403312 | LOC407835 | LOC414300 | LOC439933 | LOC440157 | LOC440300 | LOC440311 | LOC440313 | LOC440700 | LOC440864 | LOC440895 | LOC440910 | LOC440982 | LOC441052 | LOC441081 | LOC441087 | LOC441179 | LOC441228 | LOC441239 | LOC441455 | LOC441666 | LOC441722 | LOC441956 | LOC442028 | LOC442497 | LOC497256 | LOC541473 | LOC550113 | LOC553139 | LOC554206 | LOC574080 | LOC606724 | LOC613266 | LOC642131 | LOC642361 | LOC642422 | LOC642502 | LOC642590 | LOC642677 | LOC642730 | LOC642846 | LOC642947 | LOC643201 | LOC643339 | LOC643406 | LOC643441